XORTX Therapeutics Inc.
XRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729214
No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.
Superinvestors holding XRTX, Q2 2026
No superinvestor reported holding XRTX in Q2 2026.